Home

Chad M. Robins, CEO and Chairman: Adaptive Biotechnologies ADPT Sell · Filed 25/02/21

Trade details

Type
Insider sale
Amount
$1,574,236.8
Shares · price
186,080 sh · $8.46 a share
Held after
2,576,701 sh
Trade date
25/02/19
Filed
25/02/21
Days to filing
2 days

Sold 6.7% of holdings

Share of holding sold
6.7%

Adaptive Biotechnologies trades, last 26 weeks

What else happened in Adaptive Biotechnologies around then

Filed or reported within 30 days of the trade day · 25/01/20~25/03/21

Chad M. Robins's recent trades

  • Chad M. Robins

    Planned saleAdaptive Biotechnologies

    $6.8M

    Filed 08/18

  • Chad M. Robins

    Planned saleAdaptive Biotechnologies

    $8M

    Filed 08/17

  • Chad M. Robins

    Sell10b5-1 planAdaptive Biotechnologies

    $1.2M

    Filed 04/08

  • Chad M. Robins

    Sell10b5-1 planAdaptive Biotechnologies

    $566K

    Filed 04/08

  • Chad M. Robins

    Planned sale10b5-1 planAdaptive Biotechnologies

    $553K

    Filed 04/08

Chad M. Robins, Chairman — sold $1.6M of Adaptive Biotechnologies ADPT · 6.7% of holdings · 10b5-1 plan | Whalegun